tirzepatide triple agonist Agonism Based Therapies for Obesity Retatrutide for weight loss: Study

Persoonlijke menopauzezorg, begeleid door artsen Zoek je de juiste ondersteuning om af te vallen

doi: 10.1039/C8TA11456K 20 LaiY.WangJ.YueN

Originally developed for treating diabetes, tirzepatide has shown significant effectiveness as an obesity treatment, helping patients achieve meaningful weight reduction while improving overall metabolic function

The figure connects the activation of GLP-1R to downstream pathways (cAMP/PKA, Epac/PI3K/Akt, AMPK/SIRT1, ERK/MAPK) that regulate mitochondrial function, autophagy, proteostasis, and stress response, all of which collectively influence the hallmarks of aging to improve both cellular and systemic resilience